Uncovering the facts, Holding government accountable.
Published:February 2, 2022
FOIA to FDA for Communications Sent by FDA Drugs Advisory Committee Regarding Aduhelm
FOIA request to the U.S. Food and Drug Administration seeking communications sent by Peripheral and Central Nervous System Drugs Advisory Committee members regarding Aduhelm (aducanumab), an Alzheimer’s drug produced by Biogen. HHS-FDA-22-0116
Select a tag below to see a full list of related documents